PEVC case study: Biotech investment with a complex capital structure

1 year ago · 25 min watch

SECTION + CREDENTIAL

EXCLUSIVE

In this real-world case study, three investors examine the valuation of a clinical-stage biotech company using three different methods. However, they arrive at similar conclusions.

Reserved for CEIV credential holders, FVS Section members and PEVC Content Subscriptions

Already a CEIV credential holder, FVS Section member or PEVC Content Subscriber?

Log in with your AICPA account

Not a CEIV credential holder, FVS Section member or PEVC Content Subscriber?

Discover the benefits of AICPA membership, Certified in Entity and Intangible Valuations credential, Forensic & Valuation Services Section membership and Private Equity and Venture Capital Topic Subscriber. To gain access to exclusive content, your first step is to join the AICPA.

Learn more about Certified in Entity and Intangible Valuations credential

Learn more about Forensic & Valuation Services Section membership